Trimethoprim Sulfamethoxazole ( DrugBank: Trimethoprim, Sulfamethoxazole )


1 disease
IDDisease name (Link within this page)Number of trials
44Wegener granulomatosis1

44. Wegener granulomatosis


Clinical trials : 92 Drugs : 106 - (DrugBank : 27) / Drug target genes : 22 - Drug target pathways : 78
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03919435
(ClinicalTrials.gov)
March 27, 20195/4/2019Trimethoprim-Sulfamethoxazole Effects on the Nasal Microbiome in Granulomatosis With PolyangiitisTrimethoprim-Sulfamethoxazole Effects on the Nasal Microbiome in Granulomatosis With PolyangiitisGranulomatosis With Polyangiitis;Wegener GranulomatosisDrug: Trimethoprim SulfamethoxazoleUniversity of PennsylvaniaNULLActive, not recruiting18 YearsN/AAll30Phase 1/Phase 2United States